Maria Karasarides | Vice-President, Head Early Assets & Biomarkers
Bristol-Myers Squibb

Day 1 - November 28 @ 13:45

Chair's Opening Remarks

Day 2 - November 29 @ 09:15

Keynote Panel: Moving to the left: The maturing applications of ct & cf DNA in oncology

• What progress has been made? Recent approvals.
• As yet untapped potential uses of ctDNA in oncology
• Success in prediction but difficulty of use in later stage development
• Do certain phenotypes amongst circulating immune cells dictate responsiveness to certain IO drugs or combinations?

Moderator: Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb

Varun Kapoor, Director, Translational Medicine, Coherus BioSciences

×

Varun Kapoor / Keynote Panel: Moving to the left: The maturing applications of ct & cf DNA in oncology

Varun Kapoor, Director, Translational Medicine,
Coherus BioSciences

Varun Kapoor, Ph.D., is the Director of Translational Medicine at Coherus Biosciences. He brings in more than 10 years of research and development experience in immuno-oncology therapies to help establish and advance translational and biomarker strategies. He completed his post-doctoral training in ...

CloseMore

Mohan Bolisetty, Associate Director, Bristol-Myers Squibb

Matt Davis, Senior Director, Molecular Biology and Sequencing, Gritstone Bio

×

Matt Davis / Keynote Panel: Moving to the left: The maturing applications of ct & cf DNA in oncology

Matt Davis, Senior Director, Molecular Biology and Sequencing,
Gritstone Bio

Matthew Davis PhD joined Gritstone Bio (NASDAQ: GRTS) in 2015 and is currently the Senior Director of Molecular Biology and Sequencing responsible for various neoantigen discovery and translational genomics efforts.  Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio...

CloseMore

Estevan Kiernan, Associate Director, Emerging Clinical Applications-Oncology, Illumina

×

Estevan Kiernan / Keynote Panel: Moving to the left: The maturing applications of ct & cf DNA in oncology

Estevan Kiernan, Associate Director, Emerging Clinical Applications-Oncology,
Illumina

Estevan Kiernan has worked in infectious disease, genetic disease and oncology molecular diagnostics 15+ years at leading biotech companies including Thermo Fisher/Life Technologies and Abbott. For the Last 7 years he has worked at Illumina to identify future clinical applications and work globally ...

CloseMore